A study published last week in the journal Vaccines found that among males ages 18-25, Moderna’s COVID-19 vaccine was associated with 8%-52% more hospitalizations for vaccine-associated myocarditis and pericarditis than the number of COVID-19 hospitalizations it prevented. The findings contradict the risk-benefit analysis conducted by the FDA.